The ESPOIR cohort: A ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients

Joint Bone Spine

Volumn 74, Issue 5, 2007, Pages 440-445

  Combe, Bernard ^a   Benessiano, Joëlle ^b   Berenbaum, Francis ^c   Cantagrel, Alain ^d   Daurès, Jean Pierre ^a   Dougados, Maxime ^e   Fardellone, Patrice ^f   Fautrel, Bruno ^g   Flipo, Réné Marc ^h   Goupille, Philippe ⁱ   Guillemin, Francis ^j   Le Loet, Xavier ^k   Logeart, Isabelle ^l   Mariette, Xavier ^m   Meyer, Olvier ^b   Ravaud, Philippe ^b   Rincheval, Nathalie ^a   Saraux, Alain ⁿ   Schaeverbeke, Thierry ^o   Sibilia, Jean ^p  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF TOURS   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k ROUEN UNIVERSITY HOSPITAL   (France)

^l Laboratoire MSD   (France)

^m UNIVERSITÉ PARIS SACLAY   (France)

ⁿ BREST UNIVERSITY HOSPITAL   (France)

^o University Hospital   (France)

^p UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Early arthritis; ESPOIR cohort; Rheumatoid arthritis; Undifferentiated arthritis

Indexed keywords

C REACTIVE PROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ARTHRITIS; ARTICLE; BONE EROSION; DATA BASE; DISEASE DURATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; JOINT SWELLING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROGNOSIS; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; ARTHRITIS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 35348906715     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.06.001     Document Type: Article

References (35)

1. Saraux A., Guedes C., Allain J., Devauchelle V., Valls I., Lamour A., et al. Survey of rheumatoid arthritis and spondylarthropathy in Brittany. J Rheumatol 26 (1999) 2622-2626
2. Pincus T., Callahan L.F., Sale W.G., Brooks A.L., Payne L.E., Vaughn W.K., et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27 (1984) 864-872
3. Dellhag B., and Bjelle A. A five-year followup of the function and activities of daily living in rheumatoid arthritis patients. Arthritis Care Res 12 (1999) 33-41
4. Wolfe F., and Hawley D.J. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 25 (1998) 2108-2117
5. Barrett E.M., Scott D.G., Wiles N.J., and Symmons D.P. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology 39 (2000) 1403-1409
6. Jantti J., Aho K., Kaarela K., and Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology 38 (1999) 1138-1141
7. Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., et al. The mortality of rheumatoid arthritis. Arthritis Rheum 37 (1994) 481-494
8. Klareskog L., van der Heijde D., de Jager J.P., Gough A., Kalden J., Malaise M., et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind retomised controlled trial. Lancet 363 (2004) 675-681
9. St Clair E.W., van der Heijde D.M., Smolen J.S., Maini R.N., Bathon J.M., Emery P., et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50 (2004) 3432-3443
10. Breedveld F., Kavanaugh A.F., Cohen S.B., Pavelka K., van Vollenhoven R., Perez J.L., et al. Early treatment of Rheumatoid Arthritis with adalimumab plus methotrexate vs adalimumab alone or methotrexate alone: the PREMIER study. Arthritis Rheum 54 (2006) 26-37
11. Saraux A., Berthelot J.M., Le Henaff C., Chales G., Thorel J.B., Hoang S., et al. Ability of the 1987 ACR criteria to predict rheumatoid arthritis in patients with early arthritis and to classify these patients two years later. Arthritis Rheum 44 (2001) 2485-2491
12. Huizinga T.W.J., Machold K.P., Breedveld F.C., Lipsky P.E., and Smolen J.S. Criteria for early rheumatoid arthritis. Arthritis Rheum 40 (2002) 1155-1159
13. Saraux A., Berthelot J.M., Le Henaff C., Mary J.Y., Chales G., Thorel J.B., et al. Value of laboratory tests for diagnosing early rheumatoid arthritis. Arthritis Care Res 47 (2002) 155-165
14. Morel J., and Combe B. How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19 (2005) 137-146
15. Visser H., le Cessie S., Vos K., Breedveld F., and Hazes J. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46 (2002) 357-365
16. Combe B., Dougados M., Goupille P., Cantagrel A., Eliaou J.F., Sibilia J., et al. Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 44 (2001) 1736-1743
17. Cunnane G., Fitzgerald O., Hummel K.M., Youssef P.P., Gay R.E., Gay S., et al. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 44 (2001) 1744-1753
18. Lanes S.F., Lanza L.L., Radensky P.W., Yood R.A., Meenan R.F., Walker A.M., et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 40 (1997) 1475-1481
19. Van Jaarsveld C.H., Jacobs J.W., Schrijvers A.J., Heurkens A.H., Haanen H.C., and Bijlsma J.W. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. Rheumatology 37 (1998) 837-847
20. Vittecoq O., Pouplin S., Krzanowska K., Jouen-Beades F., Menard J.F., Gayet A., et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42 (2003) 939-946
21. Saulot V., Vittecoq O., Salle V., Drouot L., Legoedec J., Le Loet X., et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum 46 (2002) 1196-1201
22. Combe B., Cantagrel A., Goupille P., Bozonnat M.C., Sibilia J., Eliaou J.F., et al. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 30 (2003) 2344-2349
23. Meyer O., Nicaise-Rolet P., Dougados M., Borsali E., Goupille P., Cantagrel A., et al. Antifilaggrin and anticitrullinated cyclic peptide antibody assays in early rheumatoid arthritis for predicting 5-year radiographic damage. Ann Rheum Dis 62 (2003) 120-126
24. Combe B., Landewe R., Lukas C., Bolosiu H., Breedveld F., Dougados M., et al. EULAR evidence recommendations for the management of early arthritis. Report of a task force of the European Steting Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 66 (2007) 34-45
25. Guillemin F., Briancon S., and Pourel J. Mesure de la capacité fonctionnelle dans la polyarthrite rhumatoïde. Adaptation française du HAQ. Rev Rhum 58 (1991) 459-465
26. Guillemin F., Coste J., Pouchot J., Gezail M., Bregeon C., Sany J., and the French quality of life in rheumatology group. The AIMS2-SF: A short form of the arthritis impact measurement scales 2. Arthritis Rheum 40 (1997) 1267-1274
27. Leplege A., Ecosse E., Verdier A., and Perneger T.V. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51 (1998) 1013-1023
28. van der Heijde D.M., van Leeuwen M.A., van Riel P.L., Koster A.M., van 't Hof M.A., van Rijswijk M.H., et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 35 (1992) 26-34
29. Symmons D.P.M., and Silman A.J. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 21 (2003) S94-S99
30. van Aken J., van Bilsen J.H.M., Allaart C.F., Huizinga T.W.J., and Breedveld F.C. The Leiden early arthritis clinic. Clin Exp Rheumatol 21 (2003) S100-S105
31. Machold K.P., Nell V.P.K., Stamm T.A., Eberl G., Steiner G., and Smolen J.S. The Austrian early arthritis registry. Clin Exp Rheumatol 21 (2003) S113-S117
32. Sokka T., Willoughby, Yazici Y., and Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clin Exp Rheumatol 21 (2003) S146-S153
33. Emery P., Breedveld F.C., Dougados M., Kalden J.R., Schiff M.H., and Smolen J.S. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61 (2002) 290-297
34. Nell V.P., Machold K.P., Eberl G., Stamm T.A., Uffmann M., and Smolen J.S. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43 (2004) 906-914
35. Lard L.R., Visser H., Speyer I., veter Horst-Bruinsma I.E., Zwinderman A.H., Breedveld F.C., et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111 (2001) 446-451